Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03571633
Title Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer (BREASTIMMU02)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Centre Leon Berard

Her2-receptor positive breast cancer


Paclitaxel + Pegfilgrastim + Trastuzumab

Paclitaxel + Trastuzumab

Age Groups: adult | senior
Covered Countries FRA

No variant requirements are available.